Article Sidebar

PDF
Date Published: 18/10/2021
Abstract Views: 146
Views PDF: 98
DOI: https://doi.org/10.51298/vmj.v506i1.1205
Issue
Vol. 506 No. 1 (2021)
Section
Các bài báo
How to Cite
Thanh Dũng, L. ., Tiến Thế, V. ., Hoài Linh, V. ., Xuân Hải, Đào ., & Văn Sỹ, T. . (2021). INITIAL RESULTS OF RADIOFREQUENCY ABLATION IN THE TREATMENT OF PULMONARY METASTASES. Vietnam Medical Journal, 506(1). https://doi.org/10.51298/vmj.v506i1.1205

INITIAL RESULTS OF RADIOFREQUENCY ABLATION IN THE TREATMENT OF PULMONARY METASTASES

Lê Thanh Dũng1, Vũ Tiến Thế2, Vũ Hoài Linh1, Đào Xuân Hải1, Thân Văn Sỹ1
1 Vietnam-Germany Friendship Hospital
2 Ninh Binh General Hospital

Main Article Content

Abstract

Purpose: To evaluate the effectiveness of radiofrequency ablation (RFA) in the treatment of pulmonary metastases. Materials and methods: a non-randomized controlled study on 20 patients with 25 lung metastases treated with RFA at Viet Duc Friendship Hospital from January 2019 to July 2021 with follow-up period within 6 months after treatment. Results: There were 9 men and 11 women (mean age of 53.05 ± 14.7; range, 16 – 71). The mean diameter of the lesions was 14.5±5.9 mm (range, 6-30). RFA was performed with thermal electrode (17G, 3cm tip) with the length of 20mm for lesions under 10mm or 30mm for lesions over 10mm. The tumor response was evaluated based on mRECIST with 92% complete necrosis, 8% partial necrosis. Complications after treatment included fever (69%), chest pain (73%), dyspnea (15.4%), mild hemoptysis (11%), mild pneumothorax (11%), chest wall inflammation (3.8%) and mild effusion (3.8%). Conclusion: RFA is a safe and effective method for the treatment of pulmonary metastases with a high complete response and a low complication rate.

Article Details

Keywords

radiofrequency ablation, lung metastasis

References

1. Meybaum, C.; Graff, M.; Fallenberg, E. M.; Leschber, G.; Wormanns, D. Contribution of CAD to the Sensitivity for Detecting Lung Metastases on Thin-Section CT - A Prospective Study with Surgical and Histopathological Correlation. Rofo 2020, 192 (1), 65–73. https://doi.org/10.1055/a-0977-3453.
2. Tongdee, T.; Tantigate, P.; Tongdee, R. Radiofrequency Ablation of Lung Metastasis Not Suitable for Surgery: Experience in Siriraj Hospital. J Med Assoc Thai 2015, 98 (10), 1019–1027.
3. Prud’homme, C.; Deschamps, F.; Moulin, B.; Hakime, A.; Al-Ahmar, M.; Moalla, S.; Roux, C.; Teriitehau, C.; de Baere, T.; Tselikas, L. Image-Guided Lung Metastasis Ablation: A Literature Review. Int J Hyperthermia 2019, 36 (2), 37–45. https://doi.org/ 10.1080/ 02656736.2019.1647358.
4. Schneider, T.; Warth, A.; Herpel, E.; Schnabel, P. A.; von Deimling, A.; Eberhardt, R.; Herth, F. J. F.; Dienemann, H.; Hoffmann, H. Intraoperative Radiofrequency Ablation of Lung Metastases and Histologic Evaluation. The Annals of Thoracic Surgery 2009, 87 (2), 379–384. https://doi.org/10.1016/j.athoracsur.2008.10.088.
5. Chua, T. C.; Sarkar, A.; Saxena, A.; Glenn, D.; Zhao, J.; Morris, D. L. Long -Term Outcome of Image-Guided Percutaneous Radiofrequency Ablation of Lung Metastases: An Open-Labeled Prospective Trial of 148 Patients. Annals of Oncology 2010, 21 (10), 2017–2022. https://doi.org/10.1093/annonc/mdq098.
6. Baère, T. de; Aupérin, A.; Deschamps, F.; Chevallier, P.; Gaubert, Y.; Boige, V.; Fonck, M.; Escudier, B.; Palussiére, J. Radiofrequency Ablation Is a Valid Treatment Option for Lung Metastases: Experience in 566 Patients with 1037 Metastases. Annals of Oncology 2015, 26 (5), 987–991. https://doi.org/10.1093/annonc/mdv037.
7. Pfannschmidt, J.; Bischoff, M.; Muley, T.; Kunz, J.; Zamecnik, P.; Schnabel, P. A.; Hoffmann, H.; Dienemann, H.; Heussel, C. P. Diagnosis of Pulmonary Metastases with Helical CT: The Effect of Imaging Techniques. Thorac Cardiovasc Surg 2008, 56 (8), 471–475. https://doi.org/10.1055/s-2008-1038887.